News
Phenomenon also occurs in critical systems found in statistical physics and is directly linked to the animal’s growth ...
Your brain and skin are interconnected—and when a disorder affects both, treatment must involve a multidisciplinary approach.
Dupixent approved by FDA for bullous pemphigoid, offering a new option for adults with the rare autoimmune skin disease following positive trial results.
9-Year-Old Girl with Devastating Skin Disorder Lives in Pain: 'I Can't Play on the Playground' (Exclusive) Tayma struggles with the most severe version of Epidermolysis Bullosa, also known as ...
Tayma struggles with the most severe version of Epidermolysis Bullosa, also known as butterfly disease, a rare disorder that causes skin to blister and crack ...
A punch biopsy reliably detected a biomarker of neurodegenerative disease in a small cohort of older adults diagnosed with idiopathic REM sleep disorder, according to a poster presented at SLEEP ...
After a poor showing of its COVID med vilobelimab in a rare skin disorder trial, German drugmaker InflaRx is going back to the drawing board.
The FDA has approved a treatment called prademagene zamikeracel (sold as Zevaskyn), as a gene therapy for people with a rare genetic skin disorder known as recessive dystrophic epidermolysis ...
Hosted on MSN2mon
FDA Approves Zevaskyn for Rare, Genetic Skin Disorder - MSNTUESDAY, April 29, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Zevaskyn (prademagene zamikeracel) for patients with the rare, genetic skin disorder recessive ...
The U.S. Food and Drug Administration approved Abeona Therapeutics' gene therapy for a rare skin disorder on Tuesday.
U.S. Food and Drug Administration on Tuesday approved Abeona Therapeutics' gene therapy for a rare skin disorder.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results